These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36238266)

  • 1. Anti-leukemic principle(s) from
    Sharma J; Prabha P; Sharma R; Gupta S; Dixit A
    Cytotechnology; 2022 Oct; 74(5):591-611. PubMed ID: 36238266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells.
    Soundararajan R; Prabha P; Rai U; Dixit A
    Evid Based Complement Alternat Med; 2012; 2012():732404. PubMed ID: 22654956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.
    Khan MF; Abutaha N; Nasr FA; Alqahtani AS; Noman OM; Wadaan MAM
    BMC Complement Altern Med; 2019 Jul; 19(1):184. PubMed ID: 31340810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd.
    Kobori M; Ohnishi-Kameyama M; Akimoto Y; Yukizaki C; Yoshida M
    J Agric Food Chem; 2008 Nov; 56(22):10515-20. PubMed ID: 18959405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats.
    Choudhary SK; Chhabra G; Sharma D; Vashishta A; Ohri S; Dixit A
    Evid Based Complement Alternat Med; 2012; 2012():293650. PubMed ID: 23320026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nardostachys chinensis induces granulocytic differentiation with the suppression of cell growth through p27(Kip1) protein-related G0/G1 phase arrest in human promyelocytic leukemic cells.
    Ju SM; Lee J; Kang JG; Jeong SO; Park JH; Pae HO; Lee GS; Kim WS; Lyu YS; Jeon BH
    Pharm Biol; 2015 Jul; 53(7):1002-9. PubMed ID: 25430995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nardostachys chinensis induces the differentiation of human promyelocytic leukemic cells through the activation of the protein kinase C-dependent extracellular signal-regulated kinase signaling pathway.
    Ju SM; Kang JG; Pae HO; Lee GS; Kim WS; Lyu YS; Jeon BH
    Int J Mol Med; 2014 Mar; 33(3):573-80. PubMed ID: 24357020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypsin and elastase inhibitors from bitter gourd (Momordica charantia LINN.) seeds: purification, amino acid sequences, and inhibitory activities of four new inhibitors.
    Hamato N; Koshiba T; Pham TN; Tatsumi Y; Nakamura D; Takano R; Hayashi K; Hong YM; Hara S
    J Biochem; 1995 Feb; 117(2):432-7. PubMed ID: 7608135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis provides insights into lignin synthesis and MAPK signaling pathway that strengthen the resistance of bitter gourd (Momordica charantia) to Fusarium wilt.
    Guan F; Shi B; Zhang J; Wan X
    Genomics; 2023 Jan; 115(1):110538. PubMed ID: 36494076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.
    Fang EF; Zhang CZ; Fong WP; Ng TB
    Apoptosis; 2012 Apr; 17(4):377-87. PubMed ID: 22134530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
    Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-ethanol extractable compounds from fruits and seeds of the bitter gourd Momordica charantia: effects on lipid metabolism in isolated rat adipocytes.
    Ng TB; Wong CM; Li WW; Yeung HW
    Am J Chin Med; 1987; 15(1-2):31-42. PubMed ID: 3318384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyranocoumarins isolated from Peucedanum praeruptorum as differentiation inducers in human leukemic HL-60 cells.
    Zhang JX; Fong WF; Wu JY; Yang M; Cheung HY
    Planta Med; 2003 Mar; 69(3):223-9. PubMed ID: 12677525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
    Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of
    Fan M; Kim EK; Choi YJ; Tang Y; Moon SH
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31487939
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity.
    Wong CM; Yeung HW; Ng TB
    J Ethnopharmacol; 1985 Jul; 13(3):313-21. PubMed ID: 4058034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells.
    Chao CY; Huang CJ
    J Biomed Sci; 2003; 10(6 Pt 2):782-91. PubMed ID: 14631118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.
    Priyanto AD; Doerksen RJ; Chang CI; Sung WC; Widjanarko SB; Kusnadi J; Lin YC; Wang TC; Hsu JL
    J Proteomics; 2015 Oct; 128():424-35. PubMed ID: 26344130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.